1. Home
  2. VALN vs SCHL Comparison

VALN vs SCHL Comparison

Compare VALN & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • SCHL
  • Stock Information
  • Founded
  • VALN 2012
  • SCHL 1920
  • Country
  • VALN France
  • SCHL United States
  • Employees
  • VALN N/A
  • SCHL N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • SCHL Books
  • Sector
  • VALN Health Care
  • SCHL Consumer Discretionary
  • Exchange
  • VALN Nasdaq
  • SCHL Nasdaq
  • Market Cap
  • VALN 510.7M
  • SCHL 478.8M
  • IPO Year
  • VALN 2021
  • SCHL 1987
  • Fundamental
  • Price
  • VALN $6.28
  • SCHL $17.14
  • Analyst Decision
  • VALN Strong Buy
  • SCHL
  • Analyst Count
  • VALN 3
  • SCHL 0
  • Target Price
  • VALN $15.33
  • SCHL N/A
  • AVG Volume (30 Days)
  • VALN 83.3K
  • SCHL 246.5K
  • Earning Date
  • VALN 05-07-2025
  • SCHL 07-17-2025
  • Dividend Yield
  • VALN N/A
  • SCHL 4.63%
  • EPS Growth
  • VALN N/A
  • SCHL N/A
  • EPS
  • VALN N/A
  • SCHL 0.65
  • Revenue
  • VALN $201,099,222.00
  • SCHL $1,592,100,000.00
  • Revenue This Year
  • VALN $18.74
  • SCHL $3.42
  • Revenue Next Year
  • VALN $29.26
  • SCHL $5.47
  • P/E Ratio
  • VALN N/A
  • SCHL $26.49
  • Revenue Growth
  • VALN 21.64
  • SCHL N/A
  • 52 Week Low
  • VALN $3.62
  • SCHL $15.77
  • 52 Week High
  • VALN $9.50
  • SCHL $38.77
  • Technical
  • Relative Strength Index (RSI)
  • VALN 47.26
  • SCHL 40.57
  • Support Level
  • VALN $6.18
  • SCHL $16.81
  • Resistance Level
  • VALN $6.54
  • SCHL $17.85
  • Average True Range (ATR)
  • VALN 0.18
  • SCHL 0.66
  • MACD
  • VALN 0.02
  • SCHL -0.11
  • Stochastic Oscillator
  • VALN 45.65
  • SCHL 5.04

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

Share on Social Networks: